Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease

Linda M Rehaume1, Thierry Jouault, Mathias Chamaillard

  • 1University of British Columbia, Centre for Microbial Disease & Immunity Research, 2259 Lower Mall, Vancouver, BC, Canada V6T 1Z4.

Trends in Immunology
|February 13, 2010
PubMed

Insights

The Nod-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome acts as a defense against Candida albicans. Dysfunctional NLRP3 may contribute to Crohn's disease by promoting fungal colonization.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Candida albicans is a common commensal fungus that can cause severe infections in immunocompromised individuals.
  • The Nod-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome is a key component of the innate immune system involved in detecting microbial threats.
  • Emerging evidence suggests a link between NLRP3 inflammasome activity and autoinflammatory conditions.

Purpose of the Study:

  • To explore the role of the NLRP3 inflammasome in host defense against Candida albicans.
  • To investigate the potential contribution of NLRP3 inflammasome dysfunction to the pathogenesis of Crohn's disease.

Main Methods:

  • Review of recent immunological investigations and proposed pathophysiological models.
  • Analysis of the dual role of NLRP3 activation in Candida infection and autoinflammatory syndromes.

Main Results:

  • NLRP3 acts as a cytosolic surveillance mechanism against germinating Candida.
  • Excessive NLRP3 activation can protect against disseminated Candida but may lead to autoinflammatory syndromes.
  • Defective NLRP3 inflammasome function may promote mucosal colonization by C. albicans, potentially contributing to Crohn's disease.

Conclusions:

  • The NLRP3 inflammasome plays a critical role in managing Candida albicans colonization and infection.
  • NLRP3 inflammasome dysregulation presents a potential molecular link between Candida and autoinflammatory diseases, including Crohn's disease.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...